Evolution of the Libyan Expanded Programme of Immunization

Suleiman Abusrewil; Ali Amgadmi; Abulgasem Eljerbi; Ibtisam Hadid; Marwan Sherif; Abdurhman Ben Suoud; Mohamed Ben Ramadan; Mohammed Kabouka; Ehmaid Ben Omer; Hajer Alkot; Susan Ehnaish; Mohamed Ibrahim; Basheer Belkhair; Inas Alhudiri

doi:10.69667/lmj.2517101

Authors

Suleiman Abusrewil The National Immunization Technical Advisory Group, Tripoli, Libya. Libyan Scientific Research Society for Vaccinology, Tripoli, Libya https://orcid.org/0000-0002-1112-4469
Ali Amgadmi The National Immunization Technical Advisory Group, Tripoli, Libya. Libyan Scientific Research Society for Vaccinology, Tripoli, Libya
Abulgasem Eljerbi The National Immunization Technical Advisory Group, Tripoli, Libya. Libyan Scientific Research Society for Vaccinology, Tripoli, Libya
Ibtisam Hadid The National Immunization Technical Advisory Group, Tripoli, Libya. Libyan Scientific Research Society for Vaccinology, Tripoli, Libya
Marwan Sherif Libyan Scientific Research Society for Vaccinology, Tripoli, Libya
Abdurhman Ben Suoud The National Immunization Technical Advisory Group, Tripoli, Libya
Mohamed Ben Ramadan The National Immunization Technical Advisory Group, Tripoli, Libya
Mohammed Kabouka The National Immunization Technical Advisory Group, Tripoli, Libya. Libyan Scientific Research Society for Vaccinology, Tripoli, Libya
Ehmaid Ben Omer The National Immunization Technical Advisory Group, Tripoli, Libya
Hajer Alkot The National Immunization Technical Advisory Group, Tripoli, Libya
Susan Ehnaish The National Immunization Technical Advisory Group, Tripoli, Libya
Mohamed Ibrahim The National Immunization Technical Advisory Group, Tripoli, Libya
Basheer Belkhair The National Immunization Technical Advisory Group, Tripoli, Libya
Inas Alhudiri Libyan Scientific Research Society for Vaccinology, Tripoli, Libya

DOI:

https://doi.org/10.69667/lmj.2517101

Abstract

Vaccines are used to prevent related diseases and complications. Vaccine is considered the most successful and cost-effective medical intervention ever introduced; it is the corner stone of primary health-care services. The Libyan vaccine program is long lasting. It started in the 1960s, and being continuously evaluated with time. Libya was the first country to introduce BCG vaccination on massive scale. Initial vaccine program involved 6 antigens. Currently, the Libyan vaccination programme is immunizing against 17 infectious diseases. However, no routine adult vaccination is implemented in Libya yet.

تُستخدم اللقاحات للوقاية من الأمراض والمضاعفات المرتبطة بها. ويُعتبر اللقاح التدخل الطبي الأكثر نجاحًا وفعالية من حيث التكلفة على الإطلاق؛ وهو حجر الزاوية لخدمات الرعاية الصحية الأولية. وبرنامج التطعيم الليبي طويل الأمد. فقد بدأ في ستينيات القرن الماضي، ويخضع للتقييم المستمر مع مرور الوقت. وكانت ليبيا أول دولة تقدم لقاح BCG على نطاق واسع. وشمل برنامج التطعيم الأولي 6 مستضدات. وحاليًا، يوفر برنامج التطعيم الليبي التحصين ضد 17 مرضًا معديًا. ومع ذلك، لم يتم تنفيذ أي تطعيم روتيني للبالغين في ليبيا حتى الآن